Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane
- 18 October 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 177 (1) , 49-56
- https://doi.org/10.1016/s0304-3835(01)00767-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min miceZeitschrift für Krebsforschung und Klinische Onkologie, 2001
- Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethaneGut, 2000
- Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)JNCI Journal of the National Cancer Institute, 1998
- Nucleolar organizer regions in adenoid cystic carcinoma of the salivary glandsEuropean Archives of Oto-Rhino-Laryngology, 1995
- Suppression of Azoxymethane‐induced Rat Colon Aberrant Crypt Foci by Dietary Protocatechuic AcidJapanese Journal of Cancer Research, 1994
- Inhibitory Effects of (—)‐Epigallocatechin Gallate on Spontaneous Hepatoma in C3H/HeNCrj Mice and Human Hepatoma‐derived PLC/PRF/5 CellsJapanese Journal of Cancer Research, 1994
- Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 ratsCarcinogenesis: Integrative Cancer Research, 1993
- Sulindac causes regression of rectal polyps in familial adenomatous polyposisGastroenterology, 1991
- Inhibitory Effect of (—)‐Epigallocatechin Gallate on Carcinogenesis with N‐Ethyl‐N′‐nitro‐N‐nitrosoguanidine in Mouse DuodenumJapanese Journal of Cancer Research, 1989
- Antitumor promoting activity of (−)‐epigallocatechin gallate, the main constituent of “Tannin” in green teaPhytotherapy Research, 1987